GeneOne Life Science, Inc. (KRX:011000)
2,460.00
+120.00 (5.13%)
At close: Sep 5, 2025
GeneOne Life Science Revenue
GeneOne Life Science had revenue of 6.81B KRW in the quarter ending June 30, 2025, a decrease of -26.67%. This brings the company's revenue in the last twelve months to 34.71B, down -14.92% year-over-year. In the year 2024, GeneOne Life Science had annual revenue of 35.72B, down -11.15%.
Revenue (ttm)
34.71B
Revenue Growth
-14.92%
P/S Ratio
6.00
Revenue / Employee
846.70M
Employees
41
Market Cap
208.38B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 35.72B | -4.48B | -11.15% |
Dec 31, 2023 | 40.20B | -8.52B | -17.48% |
Dec 31, 2022 | 48.72B | 10.02B | 25.89% |
Dec 31, 2021 | 38.70B | -2.80B | -6.75% |
Dec 31, 2020 | 41.50B | 261.48M | 0.63% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
PharmaResearch | 449.81B |
Peptron | 5.18B |
LigaChem Biosciences | 148.28B |